Identifying Professional Education Gaps and Barriers in Multiple Myeloma Patient Care: Findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee-Reference-Cited by-同舟云学术

Identifying Professional Education Gaps and Barriers in Multiple Myeloma Patient Care: Findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee

Published:2014-10 Issue:5 Volume:14 Page:356-369
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Raje Noopur,Faiman Beth,Harvey R. Donald,Kurtin Sandra E.,Lonial Sagar,Kumar Shaji K.,Cohen Adam D.,Conde Miguel A.,Giralt Sergio A.,Recine Marie Sabo^ORCID,Tombler Eugene R.,Stadtmauer Edward,Jagannath Sundar,Anderson Kenneth C.

Funder

Millennium: The Takeda Oncology Company

Celgene

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference149 articles.

1. Multiple myeloma;Kyle;Blood,2008

2. Antitumor activity of thalidomide in refractory multiple myeloma;Singhal;N Engl J Med,1999

3. Treatment of plasma cell dyscrasias with thalidomide and its derivatives;Dimopoulos;J Clin Oncol,2003

4. National Comprehensive Cancer Network (NCCN) Highlights of the First Annual NCCN Hematologic Malignancies Congress. Multiple myeloma: recent advances in induction therapy and transplant options (2006).

5. New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG);Ocio;Leukemia,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panel;Blood Cancer Journal;2024-08-27

2. Real-World Registry on the Pharmacotherapy of Multiple Myeloma and Associated Renal and Pulmonary Impairments in the Greater Gulf Region: Protocol for a Retrospective Real-World Data Study;JMIR Research Protocols;2024-04-24

3. Management of Multiple Myeloma in the Middle East: Unmet Needs, Challenges and Perspective;Clinical Hematology International;2022-08-30

4. Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies;Clinical Lymphoma Myeloma and Leukemia;2018-03

5. Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes;Clinical Lymphoma Myeloma and Leukemia;2017-09